PON1 and polycystic ovary syndrome: Furthermore, previous studies found that women with polycystic ovary syndrome had decreased lactonase activity in their paraoxonase 1 enzyme, which is known to degrade QS signals [58] as well as raise testosterone levels and CRC risk [58, 59], further suggesting a potential connection between endocrine signaling, QS, and CRC.